Literature DB >> 26069293

Recurrent deletions of IKZF1 in pediatric acute myeloid leukemia.

Jasmijn D E de Rooij1, Eva Beuling1, Marry M van den Heuvel-Eibrink2, Askar Obulkasim1, André Baruchel3, Jan Trka4, Dirk Reinhardt5, Edwin Sonneveld6, Brenda E S Gibson7, Rob Pieters8, Martin Zimmermann4, C Michel Zwaan1, Maarten Fornerod9.   

Abstract

IKAROS family zinc finger 1/IKZF1 is a transcription factor important in lymphoid differentiation, and a known tumor suppressor in acute lymphoid leukemia. Recent studies suggest that IKZF1 is also involved in myeloid differentiation. To investigate whether IKZF1 deletions also play a role in pediatric acute myeloid leukemia, we screened a panel of pediatric acute myeloid leukemia samples for deletions of the IKZF1 locus using multiplex ligation-dependent probe amplification and for mutations using direct sequencing. Three patients were identified with a single amino acid variant without change of IKZF1 length. No frame-shift mutations were found. Out of 11 patients with an IKZF1 deletion, 8 samples revealed a complete loss of chromosome 7, and 3 cases a focal deletion of 0.1-0.9Mb. These deletions included the complete IKZF1 gene (n=2) or exons 1-4 (n=1), all leading to a loss of IKZF1 function. Interestingly, differentially expressed genes in monosomy 7 cases (n=8) when compared to non-deleted samples (n=247) significantly correlated with gene expression changes in focal IKZF1-deleted cases (n=3). Genes with increased expression included genes involved in myeloid cell self-renewal and cell cycle, and a significant portion of GATA target genes and GATA factors. Together, these results suggest that loss of IKZF1 is recurrent in pediatric acute myeloid leukemia and might be a determinant of oncogenesis in acute myeloid leukemia with monosomy 7. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26069293      PMCID: PMC4800704          DOI: 10.3324/haematol.2015.124321

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  47 in total

1.  Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.

Authors:  R Jäger; H Gisslinger; F Passamonti; E Rumi; T Berg; B Gisslinger; D Pietra; A Harutyunyan; T Klampfl; D Olcaydu; M Cazzola; R Kralovics
Journal:  Leukemia       Date:  2010-05-27       Impact factor: 11.528

2.  NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

Authors:  Iris H I M Hollink; Marry M van den Heuvel-Eibrink; Susan T C J M Arentsen-Peters; Marta Pratcorona; Saman Abbas; Jenny E Kuipers; Janneke F van Galen; H Berna Beverloo; Edwin Sonneveld; Gert-Jan J L Kaspers; Jan Trka; Andre Baruchel; Martin Zimmermann; Ursula Creutzig; Dirk Reinhardt; Rob Pieters; Peter J M Valk; C Michel Zwaan
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

Review 3.  Biology, risk stratification, and therapy of pediatric acute leukemias: an update.

Authors:  Ching-Hon Pui; William L Carroll; Soheil Meshinchi; Robert J Arceci
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

4.  Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells.

Authors:  Jie Jiang; Hui Yu; Yan Shou; Geoffrey Neale; Sheng Zhou; Taihe Lu; Brian P Sorrentino
Journal:  Blood       Date:  2010-04-14       Impact factor: 22.113

5.  Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.

Authors:  Thorsten Klampfl; Ashot Harutyunyan; Tiina Berg; Bettina Gisslinger; Martin Schalling; Klaudia Bagienski; Damla Olcaydu; Francesco Passamonti; Elisa Rumi; Daniela Pietra; Roland Jäger; Lisa Pieri; Paola Guglielmelli; Ilaria Iacobucci; Giovanni Martinelli; Mario Cazzola; Alessandro M Vannucchi; Heinz Gisslinger; Robert Kralovics
Journal:  Blood       Date:  2011-04-29       Impact factor: 22.113

Review 6.  Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.

Authors:  Carlos A Tirado; Federico Valdez; Laura Klesse; Nitin J Karandikar; Naseem Uddin; Arnaldo Arbini; Nicholas Fustino; Robert Collins; Sangeeta Patel; Ruth L Smart; Rolando Garcia; Jeff Doolittle; Weina Chen
Journal:  Cancer Genet Cytogenet       Date:  2010-07-01

7.  IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.

Authors:  Giovanni Martinelli; Ilaria Iacobucci; Clelia Tiziana Storlazzi; Marco Vignetti; Francesca Paoloni; Daniela Cilloni; Simona Soverini; Antonella Vitale; Sabina Chiaretti; Giuseppe Cimino; Cristina Papayannidis; Stefania Paolini; Loredana Elia; Paola Fazi; Giovanna Meloni; Sergio Amadori; Giuseppe Saglio; Fabrizio Pane; Michele Baccarani; Robin Foà
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

8.  Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy.

Authors:  Tohru Fujiwara; Henriette O'Geen; Sunduz Keles; Kimberly Blahnik; Amelia K Linnemann; Yoon-A Kang; Kyunghee Choi; Peggy J Farnham; Emery H Bresnick
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

9.  BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Authors:  Charles G Mullighan; Christopher B Miller; Ina Radtke; Letha A Phillips; James Dalton; Jing Ma; Deborah White; Timothy P Hughes; Michelle M Le Beau; Ching-Hon Pui; Mary V Relling; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2008-04-13       Impact factor: 49.962

10.  Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).

Authors:  Ilaria Iacobucci; Clelia Tiziana Storlazzi; Daniela Cilloni; Annalisa Lonetti; Emanuela Ottaviani; Simona Soverini; Annalisa Astolfi; Sabina Chiaretti; Antonella Vitale; Francesca Messa; Luciana Impera; Carmen Baldazzi; Pietro D'Addabbo; Cristina Papayannidis; Angelo Lonoce; Sabrina Colarossi; Marco Vignetti; Pier Paolo Piccaluga; Stefania Paolini; Domenico Russo; Fabrizio Pane; Giuseppe Saglio; Michele Baccarani; Robin Foà; Giovanni Martinelli
Journal:  Blood       Date:  2009-07-09       Impact factor: 22.113

View more
  19 in total

1.  Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets.

Authors:  Svea Stratmann; Sara A Yones; Markus Mayrhofer; Nina Norgren; Aron Skaftason; Jitong Sun; Karolina Smolinska; Jan Komorowski; Morten Krogh Herlin; Christer Sundström; Anna Eriksson; Martin Höglund; Josefine Palle; Jonas Abrahamsson; Kirsi Jahnukainen; Monica Cheng Munthe-Kaas; Bernward Zeller; Katja Pokrovskaja Tamm; Lucia Cavelier; Linda Holmfeldt
Journal:  Blood Adv       Date:  2021-02-09

2.  Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency.

Authors:  Kevin E Fisher; Amy P Hsu; Christopher L Williams; Hadi Sayeed; Brian Y Merritt; M Tarek Elghetany; Steven M Holland; Alison A Bertuch; Maria Monica Gramatges
Journal:  Blood Adv       Date:  2017-02-27

3.  Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis.

Authors:  Florian Renosi; Anne Roggy; Ambre Giguelay; Lou Soret; Pierre-Julien Viailly; Meyling Cheok; Sabeha Biichle; Fanny Angelot-Delettre; Vahid Asnafi; Elizabeth Macintyre; Sandrine Geffroy; Mary Callanan; Tony Petrella; Eric Deconinck; Etienne Daguindau; Véronique Harrivel; Sabrina Bouyer; Véronique Salaun; Pascale Saussoy; Jean Feuillard; Pascal Fuseau; Philippe Saas; Olivier Adotévi; Fabrice Jardin; Christophe Ferrand; Claude Preudhomme; Jacques Colinge; Christophe Roumier; Francine Garnache-Ottou
Journal:  Blood Adv       Date:  2021-03-09

Review 4.  Myeloid neoplasms with germline DDX41 mutation.

Authors:  Jesse J C Cheah; Christopher N Hahn; Devendra K Hiwase; Hamish S Scott; Anna L Brown
Journal:  Int J Hematol       Date:  2017-05-25       Impact factor: 2.490

Review 5.  The Philadelphia chromosome in leukemogenesis.

Authors:  Zhi-Jie Kang; Yu-Fei Liu; Ling-Zhi Xu; Zi-Jie Long; Dan Huang; Ya Yang; Bing Liu; Jiu-Xing Feng; Yu-Jia Pan; Jin-Song Yan; Quentin Liu
Journal:  Chin J Cancer       Date:  2016-05-27

6.  Hepatic Transcriptome Profiles of Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E.

Authors:  Masuko Kobori; Yumiko Takahashi; Mutsumi Sakurai; Yinhua Ni; Guanliang Chen; Mayumi Nagashimada; Shuichi Kaneko; Tsuguhito Ota
Journal:  Int J Mol Sci       Date:  2017-03-08       Impact factor: 5.923

Review 7.  The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia.

Authors:  René Marke; Frank N van Leeuwen; Blanca Scheijen
Journal:  Haematologica       Date:  2018-03-08       Impact factor: 9.941

8.  An integrative ENCODE resource for cancer genomics.

Authors:  Jing Zhang; Donghoon Lee; Vineet Dhiman; Peng Jiang; Jie Xu; Patrick McGillivray; Hongbo Yang; Jason Liu; William Meyerson; Declan Clarke; Mengting Gu; Shantao Li; Shaoke Lou; Jinrui Xu; Lucas Lochovsky; Matthew Ung; Lijia Ma; Shan Yu; Qin Cao; Arif Harmanci; Koon-Kiu Yan; Anurag Sethi; Gamze Gürsoy; Michael Rutenberg Schoenberg; Joel Rozowsky; Jonathan Warrell; Prashant Emani; Yucheng T Yang; Timur Galeev; Xiangmeng Kong; Shuang Liu; Xiaotong Li; Jayanth Krishnan; Yanlin Feng; Juan Carlos Rivera-Mulia; Jessica Adrian; James R Broach; Michael Bolt; Jennifer Moran; Dominic Fitzgerald; Vishnu Dileep; Tingting Liu; Shenglin Mei; Takayo Sasaki; Claudia Trevilla-Garcia; Su Wang; Yanli Wang; Chongzhi Zang; Daifeng Wang; Robert J Klein; Michael Snyder; David M Gilbert; Kevin Yip; Chao Cheng; Feng Yue; X Shirley Liu; Kevin P White; Mark Gerstein
Journal:  Nat Commun       Date:  2020-07-29       Impact factor: 14.919

9.  Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1.

Authors:  Dennis Liang Fei; Tao Zhen; Benjamin Durham; John Ferrarone; Tuo Zhang; Lisa Garrett; Akihide Yoshimi; Omar Abdel-Wahab; Robert K Bradley; Paul Liu; Harold Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-15       Impact factor: 11.205

Review 10.  Cellular signaling and epigenetic regulation of gene expression in leukemia.

Authors:  Chandrika Gowda; Chunhua Song; Yali Ding; Soumya Iyer; Pavan K Dhanyamraju; Mary McGrath; Yevgeniya Bamme; Mario Soliman; Shriya Kane; Jonathon L Payne; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2019-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.